Cholesterol Lowering Drugs Market Trends, Business Overview,
Industry Growth and Forecast to 2031

The global cholesterol lowering drugs market is anticipated
to grow at a significant CAGR during the forecast period (2024-2031). In
general, cholesterol is considered to be fundamentally required by the body,
however, more than 240 mg/dl is termed as high cholesterol. A total cholesterol
of 200 mg/dl or lower is acceptable, and 200–240 mg/dl is considered borderline
high. Such excessive level of cholesterol in the blood is known as
hypercholesterolemia. High cholesterol may be a result of imbalanced diet,
genetic diseases, obesity, or other diseases such as diabetes and an
underactive thyroid. For instance, as per the International Diabetes Federation
(IDF), the total adult population in the US suffering from diabetes was 31
million in 2019 while in Canada, it was 2.8 million. Moreover, there were
around 189,000 mortalities due to diabetes in the US in 2019, which represents
one of the highest numbers of mortalities all around the globe. Thus, the
increased prevalence of diabetes as a result of high cholesterol is primarily
driving the demand for cholesterol lowering drugs.

Get Free Sample link @ https://www.omrglobal.com/request-sample/cholesterol-lowering-drugs-market

Apart from the common factors such as sedentary routines,
increase in the consumption of saturated and trans-fat is also responsible for
elevated levels of cholestrol all over the globe. The global cholesterol
lowering drugs market is further likely to grow owing to the emergence of new
drug classes, more effective therapies such as PCSK9 inhibitors, bempedoic
acid, and the novel drugs in their pipeline phase. Although the major side
effects of statins causing rhabdomyolysis as well as the easy accessibility to
generic drugs of leading brands are projected to restrain the market growth
during the forecast period. 

Full report of Cholesterol Lowering Drugs Market available @
https://www.omrglobal.com/industry-reports/cholesterol-lowering-drugs-market

Market Coverage

    • Segment Covered- 

o             By Drug
Class

o             By
Indication

•             Regions
covered-

o             North
America

o             Europe

o             Asia-Pacific

o             Rest of
the World

    • Competitive Landscape:  AstraZeneca
plc, Sanofi S.A., and Merck & Co., Inc., among others. 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market
in the base year?

    • Which segment and region will project the
fastest growth in the market?

    • How COVID-19 impacted the market?

o             Deviation
from the pre-COVID-19 forecast

o             Most
affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to
sustain growth?

    • Where is the investment opportunity?

Global Cholesterol Lowering Drugs Market Report by
Segment

By Drug Class

•      
Statins & Combination

•      
PCSK9 Inhibitor

•      
Bile Acid Sequestrants

•      
Fibrates

•      
Cholesterol Absorption Inhibitors

•      
Others

By Indication

•      
Hypercholesterolemia 

•      
Coronary Artery Inhibitors

•      
Higher Triglycerides

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cholesterol-lowering-drugs-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.